Genus PLC
14 February 2002
For Immediate Release: 07.00, 14 February 2002
GENUS PLC
A Bulls Eye for Genus' Research & Development
Genus PLC, the fast-growing provider of technology for agriculture, has
developed a new 'designer' bull called Machoman which is the World Leader and
Best in Breed according to the United States Department of Agriculture.
Machoman is the latest product of Genus' £8 million per year Research and
Development programme which engineered its specially designed genes enabling it
to beat 750 other prize bulls to the title.
The ranking, which gives Machoman world leadership, is based on highest type
merit involving numerous tests on both output and robustness of the bull's
calves.
Genus' Breeding division is the World's leading cattle semen company. Its
research and development identifies improved cattle genetics which are sold to
farmers in 70 countries in the form of bull semen. Machoman, currently in the
stud in Canada, is expected to produce 120,000 doses of semen a year, each of
which will be priced at a premium rate so that world wide sales should exceed $5
million, and shipping to worldwide destinations is expected to begin shortly.
Richard Wood, Chief Executive of Genus plc, commenting on this accolade, said:
'To have been awarded this highly prestigious international ranking proves that
Genus' research programme is unequalled in the area of practical genetic
research. Prospective suitors are queuing up world-wide to receive this
acclaimed semen. Machoman has joined our stable of decorated bulls in three
continents.'
- END -
For further information, please contact :
Genus Tel: +44 (0)1270 536 500
Richard Wood, Chief Executive
Buchanan Communications Tel: +44 (0)20 7466 5000
Nicola How / Catherine Miles
Notes to Editors:
Genus is a leader of technology and service in cattle breeding, agricultural
consulting and the distribution of products in the veterinary market. In July
2000 Genus moved from the OFEX Exchange of the London Stock Exchange to the
Alternative Investment Market and is now established as a visionary
international company trading in over 70 countries with three substantial
complementary divisions:
• Genus Breeding: Genus Breeding is the global market leader in cattle
breeding. It's cutting edge technology is being used to improve the quality of
beef and dairy herds worldwide.
• Genus Consulting: Genus Consulting offers services to the complete food
chain. It provides information, consulting advice and solutions to farmers,
growers, food manufacturers, agri-business and national and international policy
makers.
• Genus Distribution: Genus Distribution is a wholesale distributor of
veterinary products, generic human pharmaceuticals and dental consumables. It
also markets branded products for the small animal sector.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.